Exact Mass: 569.1827770000001

Exact Mass Matches: 569.1827770000001

Found 29 metabolites which its exact mass value is equals to given mass value 569.1827770000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Firsocostat

2-{1-[2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-3-yl}-2-methylpropanoic acid

C28H31N3O8S (569.1831766)

Emricasan

(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid

C26H27F4N3O7 (569.178504)

Guanosine, 2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo(a)pyren-10-yl)-

9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-({4,5,6-trihydroxypentacyclo[10.6.2.0^{2,7}.0^{9,19}.0^{16,20}]icosa-1(19),2(7),8,10,12(20),13,15,17-octaen-3-yl}amino)-6,9-dihydro-1H-purin-6-one

C30H27N5O7 (569.1910392)

Astin C

C25H33Cl2N5O6 (569.1807778)

Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1].

C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone

NCGC00384857-01_C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone

C25H33Cl2N5O6 (569.1807778)

N2-Benzo(a)pyrene-triol-deoxyguanosine

C30H27N5O7 (569.1910392)

Cys Met Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C24H35N5O5S3 (569.180022)

Cys Met Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Cys Trp Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Met Cys Met Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C24H35N5O5S3 (569.180022)

Met Cys Trp Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Met Met Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C24H35N5O5S3 (569.180022)

Met Met Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C24H35N5O5S3 (569.180022)

Met Trp Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Met Trp Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C24H35N5O5S3 (569.180022)

Trp Cys Met Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Trp Met Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C24H35N5O5S3 (569.180022)

Trp Met Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C24H35N5O5S3 (569.180022)

Emricasan

C26H27F4N3O7 (569.178504)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Firsocostat (ND-630; GS-0976; NDI-010976) is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively.

7,8-Dihydrofolate diglutamate

C24H25N8O9-3 (569.174442)

(+)-trans-anti-BPDE-N2-dG

C30H27N5O7 (569.1910392)

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C25H33Cl2N5O6 (569.1807778)

(3r,6r,13r,17s,18r,18as)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C25H33Cl2N5O6 (569.1807778)

n-(6-{[(1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy}-3-hydroxy-2-methyloxan-4-yl)ethanimidic acid

C29H31NO11 (569.1897016)